Open an account

Palatin Technologies

PTN · NYSE American

$5.52−$0.47 (−7.85%)TodayMarket closed ·
Prev close $5.99

About PTN

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. The company is headquartered in Cranbury, New Jersey and currently employs 29 full-time employees. The firm is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. The MCR system has effects on inflammation and immune system response, food intake, metabolism, and sexual function. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. Its product development activities focus primarily on the use of MC4R agonists for treatment of obesity. The company develops MC4R peptides and small molecule agonists with potential utility in obesity and metabolic-related disorders, rare MC4R pathway diseases, such as hypothalamic obesity, and orphan indications. The company also develops MC1R agonist products to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease.

Employees
29
Headquarters
Cranbury, New Jersey
Listed
Dec 21, 1999
Sector
Health Care
Industry
Biotechnology
Website
palatin.com

PTN key statistics

Market cap
9.83M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
30.12K
Volume
64.65K
Open price
$5.99
High today
$5.99
Low today
$5.40
52 Week high
$31.00
52 Week low
$5.55

Palatin Technologies (PTN) at a glance

As of Oct 20, 2026, Palatin Technologies (PTN) shares are priced at $5.52, giving the company a market cap of 9.83M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $5.40 and $5.99. The current price is 2.2% above the day's low and 7.8% below its high.

Volume so far is 64.65K shares, above the average of 30.12K shares a day.

Over the past year Palatin Technologies has ranged from $5.55 to $31.00, and now sits 0% of the way up that range.

Palatin Technologies met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q4 FY26 it reported -$1.11 per share against an estimate of -$1.21.

The average analyst price target is $54.57, 888.6% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $54.57
Low
$47.97
Now
$5.52
High
$63.00

PTN earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 5 of the last 8 quarters, by 37.2% on average.

  1. Q3 FY24: reported -$26.50 per share against an estimate of -$25.08
  2. Q4 FY24: reported -$25.00 per share against an estimate of -$28.03
  3. Q1 FY25: reported -$19.50 per share against an estimate of -$25.75
  4. Q2 FY25: reported -$6.00 per share against an estimate of -$21.21
  5. Q3 FY25: reported -$9.00 per share against an estimate of -$8.59
  6. Q2 FY26: reported -$2.86 per share against an estimate of -$2.38
  7. Q3 FY26: reported -$0.37 per share against an estimate of -$1.26
  8. Q4 FY26: reported -$1.11 per share against an estimate of -$1.21

PTN news

  • Avi Kapoor

    Gold Fields, Harmony Gold Mining, Anglogold Ashanti And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

  • Press releasePRNewswire

    Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update

  • Avi Kapoor

    Why Webuy Global Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

  • Press releasePRNewswire

    Palatin to Begin Trading on Nasdaq Stock Exchange

  • Press releasePRNewswire

    Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

  • Press releasePRNewswire

    Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • Press releasePRNewswire

    Palatin Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

Similar companies

Companies in the same industry as Palatin Technologies

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.